Cite
HARVARD Citation
Herold, M. et al. (2022). Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial. HemaSphere. 6 (3), pp. e699-. [Online].